Search Results - "SKARLOS, D. V"

Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone by Christodoulou, C, Pervena, A, Klouvas, G, Galani, E, Falagas, M E, Tsakalos, G, Visvikis, A, Nikolakopoulou, A, Acholos, V, Karapanagiotidis, G, Batziou, E, Skarlos, D V

“…The use of bisphosphonates is associated with osteonecrosis of the jaw (ONJ). Antiangiogenic agents are used with increasing frequency and may induce the risk…”
Get more information

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases by Christodoulou, C., Bafaloukos, D., Kosmidis, P., Samantas, E., Bamias, A., Papakostas, P., Karabelis, A., Bacoyiannis, C., Skarlos, D. V.

“…Purpose: To determine the efficacy, tolerability, and safety of temozolomide in heavily pretreated patients with solid tumors and brain metastases. Patients…”
Get full text

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial by Skarlos, P., Christodoulou, C., Kalogeras, K. T., Eleftheraki, A. G., Bobos, M., Batistatou, A., Valavanis, C., Tzaida, O., Timotheadou, E., Kronenwett, R., Wirtz, R. M., Kostopoulos, I., Televantou, D., Koutselini, E., Papaspirou, I., Papadimitriou, C. A., Pectasides, D., Gogas, H., Aravantinos, G., Pavlidis, N., Arapantoni, P., Skarlos, D. V., Fountzilas, G.

“…Purpose It is well recognized that breast cancer is a heterogeneous disease. The purpose of the current study was to classify patients according to the…”
Get full text

Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG) by Skarlos, D.V., Samantas, E., Briassoulis, E., Panoussaki, E., Pavlidis, N., Kalofonos, H. P., Kardamakis, D., Tsiakopoulos, E., Kosmidis, P., Tsavdaridis, D., Tzitzikas, J., Tsekeris, P., Kouvatseas, G., Zamboglou, N., Fountzilas, G.

“…Summary Background Concurrent platinum-etoposide chemotherapy given in combination with hyperfractionated thoracic radiation therapy (HTRT) in limited disease…”
Get full text

Performance Status (PS): A Simple Predictor of Short-term Outcome of Cancer Patients with Solid Tumors Admitted to the Intensive Care Unit (ICU) by CHRISTODOULOU, C, RIZOS, M, GALANI, E, RELLOS, K, SKARLOS, D. V, MICHALOPOULOS, A

“…Background: Admission of cancer patients with serious medical complications to the Intensive Care Unit (ICU) remains controversial. The aim of this study was…”
Get full text

Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients by Murray, S., Timotheadou, E., Linardou, H., Vrettou, A.V., Kostopoulos, I., Skrickova, J., Papakostantinou, C., Christodoulou, C., Pectasides, D., Samantas, E., Papakostas, P., Skarlos, D.V., Kosmidis, P., Fountzilas, G.

“…Somatic tyrosine kinase (TK) domain mutations of the epidermal growth factor receptor (EGFR) gene are associated with sensitivity of non-small cell lung cancer…”
Get full text

A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: A Hellenic Cooperative Oncology Group Study by Kalofonos, H.P, Bamias, A, Koutras, A, Papakostas, P, Basdanis, G, Samantas, E, Karina, M, Misailidou, D, Pisanidis, N, Pentheroudakis, G, Economopoulos, T, Papadimitriou, C, Skarlos, D.V, Pectasides, D, Stavropoulos, M, Bafaloukos, D, Kardamakis, D, Karanikiotis, C, Vourli, G, Fountzilas, G

“…Abstract The primary objective was to compare the 3-year survival of rectal cancer patients randomised postoperatively to irinotecan (IRI), Leucovorin (LV) and…”
Get full text

Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention by Christodoulou, C., Tsakalos, G., Galani, E., Skarlos, D.V.

Get full text

Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study by Aravantinos, G., Fountzilas, G., Kosmidis, P., Dimopoulos, M. A., Stathopoulos, G. P., Pavlidis, N., Bafaloukos, D., Papadimitriou, C., Karpathios, S., Georgoulias, V., Papakostas, P., Kalofonos, H. P., Grimani, E., Skarlos, D. V.

“…Background: We compared the combination plus Carboplatin plus paclitaxel, which is considered the treatment of choice for initial chemotherapy of advanced…”
Get full text

Guillain-Barré syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy by Christodoulou, C, Anastasopoulos, D, Visvikis, A, Mellou, S, Detsi, I, Tsiakalos, G, Pateli, A, Klouvas, G, Papadimitriou, A, Skarlos, D. V

“…We report Guillain-Barré syndrome (GBS), developed in a patient with metastatic colon cancer, receiving oxaliplatin-based chemotherapy. The 53-year-old patient…”
Get full text

Epithelial Ovarian Cancer in Greece: A Retrospective Study of 1,791 Patients by the Hellenic Cooperative Oncology Group (HeCOG) by PECTASIDES, D, PAPAXOINIS, G, SKARLOS, D. V, ECONOMOPOULOS, T, DIMOPOULOS, M. A, FOUNTZILAS, G, ARAVANTINOS, G, BAMIAS, A, PAVLIDIS, N, KALOFONOS, H. P, TIMOTHEADOU, E, SAMANTAS, E, BRIASOULIS, E

“…Background: The aim of this retrospective study was to present the epidemiological, pathological and clinical characteristics and treatment results of Greek…”
Get full text

Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer by Christodoulou, C, Klouvas, G, Pateli, A, Mellou, S, Sgouros, J, Skarlos, D V

“…To evaluate the efficacy and safety of weekly paclitaxel and trastuzumab in patients with HER2-positive metastatic breast cancer, with trastuzumab administered…”
Get more information

A Randomized Trial to Compare the Efficacy and Safety of Antiemetic Treatment with Ondansetron and Ondansetron Zydis in Patients with Breast Cancer Treated with High-dose Epirubicin by PECTASIDES, D, DAFNI, U, ARAVANTINOS, G, TIMOTHEADOU, E, SKARLOS, D. V, PAVLIDIS, N, GAGLIA, A, KALOFONOS, H. P, FOUNTZILAS, G

“…Objective: The objective of this study was to compare the efficacy of a disintegrating tablet of ondansetron (ODT) and the conventional tablet formulation of…”
Get full text

Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia by Christodoulou, C, Klouvas, G, Efstathiou, E, Zervakis, D, Papazachariou, E, Plyta, M, Skarlos, D V

“…To study the effectiveness of the MSC cold cap system to prevent chemotherapy-induced alopecia. The system was applied in 83 cancer patients (mean age 49.8…”
Get more information

Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study by Christodolou, C, Pavlidis, N, Samantas, E, Fountzilas, G, Kouvatseas, G, Pagdatoglou, K, Palamidas, F, Nikolaidis, C, Angelidou, M, Kalofonos, H P, Kosmidis, P, Skarlos, D V

“…Prognostic factors among Greek patients with SCLC were evaluated. Data from 516 patients with SCLC treated by the Hellenic Cooperative Oncology Group were…”
Get more information

Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer by Aravantinos, G., Dimopoulos, M. A., Kosmidis, P., Bafaloukos, D., Papadimitriou, C., Kiamouris, C., Pavlidis, N., Sikiotis, K., Papakostas, P., Skarlos, D.V.

“…Background: The prognosis of platinum resistant ovarian cancer is very poor and the treatment of choice has not been clearly defined. Patients and methods: We…”
Get full text

Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel by Koutras, A K, Kotoula, V, Papadimitriou, C, Dionysopoulos, D, Zagouri, F, Kalofonos, H P, Kourea, H P, Skarlos, D V, Samantas, E, Papadopoulou, K, Kosmidis, P, Pectasides, D, Fountzilas, G

“…The aim of the study was to evaluate the association of vascular endothelial growth factor ( VEGF ) genotypes with treatment efficacy in a phase II trial. This…”
Get full text

Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer by Samantas, E., Skarlos, D.V., Pectasides, D., Nicolaides, P., Kalofonos, H., Mylonakis, N., Vardoulakis, Th, Kosmidis, P., Pavlidis, N., Fountzilas, G.

“…Sixty patients with poor prognostic features, either with extensive disease (ED) or limited disease (LD) small cell lung cancer (SCLC), were treated on an…”
Get full text

Docetaxel in combination with dacarbazine in patients with advanced melanoma by Bafaloukos, D, Aravantinos, G, Fountzilas, G, Stathopoulos, G, Gogas, H, Samonis, G, Briasoulis, E, Mylonakis, N, Skarlos, D V, Kosmidis, P

“…The number of agents that are active in patients with metastatic melanoma is limited and cure is not a realistic objective for treatment at this stage. The aim…”
Get more information

Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study by Skarlos, D V, Aravantinos, G, Linardou, E, Kostakopoulos, C A, Kastriotis, I, Christodoulou, C, Picramenos, D, Giannakakis, T, Dimopoulos, K, Fountzilas, G

“…We conducted a phase II study in order to assess the efficacy and toxicity of Carbo-MVE (carboplatin 250 mg/m2 i.v. day 1, methotrexate 25 mg/m2 i.v. days 1,…”
Get more information